FDA grants accelerated approval for SIRTURO™ (bedaquiline)
31 December 2012 | By Johnson & Johnson
FDA has granted accelerated approval to SIRTURO™ Tablets for the treatment of pulmonary multi-drug resistant tuberculosis...
List view / Grid view
31 December 2012 | By Johnson & Johnson
FDA has granted accelerated approval to SIRTURO™ Tablets for the treatment of pulmonary multi-drug resistant tuberculosis...
19 July 2011 | By Janssen Therapeutics
Janssen Therapeutics, presented 96-week findings from two pivotal Phase 3 clinical trials...